Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding

被引:67
作者
Jones, Dylan T. [1 ]
Harris, Adrian L. [1 ]
机构
[1] John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK Growth Factor Grp, Oxford OX3 9DS, England
关键词
D O I
10.1158/1535-7163.MCT-05-0443
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia-inducible factor-alpha (Hif-alpha) plays an important role in tumor growth by increasing resistance to apoptosis and the production of angiogenic factors, such as vascular endothelial growth factor (VEGF). Therefore, Hif-alpha is an attractive target for development of novel cancer therapeutics. We have generated Chinese hamster ovary cells, which stably express luciferase reporter construct under the control of a hypoxia response element to screen 15,000 compounds. We identified 40 compounds that inhibited hypoxic up-regulation of luciferase, and the top 30 compounds were further screened in a secondary assay using MDA-468 breast cancer cell line. Eight compounds were shown to inhibit VEGF expression in hypoxic cells at subtoxic concentrations. Three top putative Hif inhibitors, DJ12, DJ15, and DJ30, were chosen for further analysis. Transient transfection of cells with hypoxia-regulated luciferase reporter plasmids further validated that these compounds inhibit hypoxia upregulated genes. All three compounds failed to inhibit Hif-1 alpha protein levels but they did inhibit induction of downstream targets of Hif-alpha under hypoxia. Two of the three compounds were cell type specific, whereas compound DJ12 inhibited VEGF at subtoxic levels in breast cancer cell lines MDA-468 and ZR-75, melanoma cell line MDA-435, and pVHL mutant renal cancer cell lines RCC4 and 786-0. Compound DJ 12 down-regulated mRNA of downstream targets of Hif-alpha, and significantly inhibited Hif-1 alpha transactivation activity by blocking Hif-1 alpha hypoxia response element-DNA binding. Our cell-based approach and deconvolution of the inhibitory effect of DJ12 has identified a novel compound that targets the hypoxia pathway by inhibiting Hif-alpha-inducible transcription.
引用
收藏
页码:2193 / 2202
页数:10
相关论文
共 50 条
[1]  
Blancher C, 2000, CANCER RES, V60, P7106
[2]   Levels of hypoxia-inducible factor-1α during breast carcinogenesis [J].
Bos, R ;
Zhong, H ;
Hanrahan, CF ;
Mommers, ECM ;
Semenza, GL ;
Pinedo, HM ;
Abeloff, MD ;
Simons, JW ;
van Diest, PJ ;
van der Wall, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04) :309-314
[3]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[4]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[5]   IRON REGULATION OF TRANSFERRIN RECEPTOR MESSENGER-RNA LEVELS REQUIRES IRON-RESPONSIVE ELEMENTS AND A RAPID TURNOVER DETERMINANT IN THE 3' UNTRANSLATED REGION OF THE MESSENGER-RNA [J].
CASEY, JL ;
KOELLER, DM ;
RAMIN, VC ;
KLAUSNER, RD ;
HARFORD, JB .
EMBO JOURNAL, 1989, 8 (12) :3693-3699
[6]   Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1α induction in response to hypoxic stress and growth factors [J].
Chau, NM ;
Rogers, P ;
Aherne, W ;
Carroll, V ;
Collins, I ;
McDonald, E ;
Workman, P ;
Ashcroft, M .
CANCER RESEARCH, 2005, 65 (11) :4918-4928
[7]   Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia [J].
Chen, CH ;
Pore, N ;
Behrooz, A ;
Ismail-Beigi, F ;
Maity, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) :9519-9525
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease [J].
Clifford, SC ;
Cockman, ME ;
Smallwood, AC ;
Mole, DR ;
Woodward, ER ;
Maxwell, PH ;
Ratcliffe, PJ ;
Maher, ER .
HUMAN MOLECULAR GENETICS, 2001, 10 (10) :1029-1038
[10]   The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase [J].
Cooper, CE ;
Lynagh, GR ;
Hoyes, KP ;
Hider, RC ;
Cammack, R ;
Porter, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20291-20299